STAT3 and metabolic dysfunction-associated steatohepatitis: From the HE staining results, it was observed that inhibition of p-STAT3 by APTSTAT3-9R significantly improved the liver pathological status of NASH mice, while this improvement can be significantly reversed by the overexpressed Anxa2 (Fig. 6 A).